April 28 (Reuters) – Diagnostic test maker Alere Inc
said its board has rejected a recent request by Abbott
Laboratories Inc to terminate the $5.8 billion deal to
buy Alere for a breakup fee.
The post Alere says it rejected Abbott’s request to end merger deal appeared first on NASDAQ.